Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / S&P SMLCP INDL
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
241,802
-
Shares change
-
-90,604
-
Total reported value, excl. options
-
$14,231,000
-
Value change
-
-$4,461,406
-
Number of buys
-
3
-
Number of sells
-
-13
-
Price
-
$58.85
Significant Holders of INVESCO EXCH TRADED FD TR II - S&P SMLCP INDL (PSCI) as of Q2 2020
22 filings reported holding PSCI - INVESCO EXCH TRADED FD TR II - S&P SMLCP INDL as of Q2 2020.
INVESCO EXCH TRADED FD TR II - S&P SMLCP INDL (PSCI) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 241,802 shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (84,318 shares), SALEM INVESTMENT COUNSELORS INC (34,308 shares), CITADEL ADVISORS LLC (30,752 shares), GOLDMAN SACHS GROUP INC (19,702 shares), MORGAN STANLEY (16,766 shares), WELLS FARGO & COMPANY/MN (15,573 shares), UBS Group AG (13,433 shares), XPONANCE, INC. (12,258 shares), ROYAL BANK OF CANADA (10,896 shares), and US BANCORP \DE\ (2,000 shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.